Clinical Trials Browser

Phase 4 × Vemurafenib × Dermatologic × Clear all

NCT01683188 2021-02-01

PROCLIVITY01

Phase 4 Terminated

Melanoma, Skin Neoplasms

NCT01898585 2020-01-07

An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic Melanoma

Phase 4 Completed

Melanoma